MMJ Reporter Trumpets Dutch Scientists’ Landmark Trial Tests of CanChew® Plus from AXIM® Biotechnologies

by adminTorusBrand | Dec 4, 2017 | Axim Biotechnologies, Media Coverage

A marijuana-focused news outlet recently spotlighted MJNA investment company AXIM® Biotechnologies and its upcoming trial of its cannabinoid-based gum for IBS. Medical Marijuana, Inc. investment company AXIM® Biotechnologies and its cannabinoid-based gum were recently...

AXIM Biotechnologies Takes First Steps Towards Clinical Trials for CBD-Based Treatment of Drug-Related Psychosis

by adminTorusBrand | Aug 3, 2017 | Axim Biotechnologies, Company News

[vc_row][vc_column][vc_column_text]Since securing additional funding last fall, AXIM® Biotechnologies has expanded its ongoing new drug research to include treatments for opioid addiction, irritable bowel syndrome, multiple sclerosis, psoriasis and eczema, and...

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis

by adminTorusBrand | Aug 3, 2017 | Axim Biotechnologies, Press Releases

SAN DIEGO, Aug. 3, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Clinical...

The CBD Hemp Oil Movement – and Medical Marijuana, Inc.’s place in it.

by adminTorusBrand | Aug 2, 2017 | Axim Biotechnologies, Company News, Dixie Botanicals, HempMeds, HempMeds Brasil, HempMeds Mexico

[vc_row][vc_column][vc_column_text]Since 2012, Mediccal Marijuana, Inc. has been recognized as an industry leader in the CBD hemp oil space. As the first company in the world to develop nationally legal CBD hemp oil products, Medical Marijuana, Inc. pioneered the path...

Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome

by adminTorusBrand | Jul 27, 2017 | Axim Biotechnologies, Press Releases

SAN DIEGO, July 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its major investment AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Services...

AXIM® Biotechnologies to Explore Cannabinoid-Based Treatment for Restless Leg Syndrome

by adminTorusBrand | Jul 21, 2017 | Axim Biotechnologies, Company News

[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies has taken the steps necessary to begin Phase II clinical trials on a cannabinoid-based functional chewing gum for the treatment of restless leg syndrome. AXIM® Biotechnologies recently entered into a Services...